Lord, Abbett & Co. LLC Gilead Sciences, Inc. Transaction History

Lord, Abbett & Co. LLC

$30.7 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Oct 07, 2024	BUY	$77.31 - $88.08 $773 - $880	10 Added 0.19%	5,220 $433,000
Q1 2023 May 12, 2023	BUY	$77.31 - $88.08 $773 - $880	10 Added 0.19%	5,220 $433,000
Q4 2022 Oct 07, 2024	BUY	$62.32 - $89.47 $324,687 - $466,138	5,210 New	5,210 $447,000
Q4 2022 Feb 10, 2023	SELL	$62.32 - $89.47 $1.48 Million - $2.12 Million	-23,740 Reduced 82.0%	5,210 $447,000
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $1.72 Million - $1.97 Million	28,950 New	28,950 $1.79 Million
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $35.2 Million - $40.9 Million	-486,390 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$62.63 - $80.22 $11.3 Million - $14.5 Million	180,452 Added 58.98%	486,390 $36.4 Million
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $1.15 Million - $1.26 Million	-18,659 Reduced 5.75%	305,938 $19.9 Million
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $178,653 - $197,202	-2,858 Reduced 0.87%	324,597 $20.6 Million
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $2.72 Million - $3.06 Million	-44,033 Reduced 11.85%	327,455 $22.1 Million
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $2.98 Million - $3.33 Million	47,600 Added 14.7%	371,488 $24.2 Million
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $1.18 Million - $1.54 Million	-19,500 Reduced 5.68%	323,888 $20.3 Million
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $5.71 Million - $6.32 Million	-80,050 Reduced 18.9%	343,388 $26.5 Million
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $4.56 Million - $5.32 Million	70,334 Added 19.92%	423,438 $30 Million
Q1 2018 May 15, 2018	BUY	$72.84 - $88.8 $25.7 Million - $31.4 Million	353,104 New	353,104 $26.6 Million
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $4.44 Million - $5.21 Million	-62,400 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $4.5 Million - $5.33 Million	62,400	62,400 $5.06 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.1 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.07 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.71 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.56 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.

Account